Navigation Links
Nobel Laureate Dr. Oliver Smithies to Deliver Plenary Session at ISPE Biotechnology Symposium
Date:7/26/2013

Tampa, FL (PRWEB) July 26, 2013

Delegates will gain from the vast knowledge of Nobel Laureate, Dr. Oliver Smithies, during his plenary session “Where Do Ideas Come From” at ISPE’s Biotechnology, a two-day Symposium August 27-28, 2013 in Durham, NC.

Smithies is the Weatherspoon Eminent Distinguished Professor of Pathology and Laboratory Medicine at University of North Carolina. In the 1950s, he described the first high resolution electrophoresis system (starch gel), and discovered that normal humans have unsuspected inherited differences in their proteins. His technique of starch-gel electrophoresis opened vast areas of new study. With this technique, Smithies uncovered protein polymorphisms in normal persons and worked on the heredity of several blood proteins.

In 1985, Smithies described his second ground-breaking technique – the use of homologous recombination to alter a human gene in a living cell. With this technique, he has determined how genes affect blood pressure in healthy persons, and how the same genes influence the kidney problems that affect some people with diabetes.

In addition to Smithies’ presentation, Dr. James Talton, CEO Nanotherapeutics and David Doleski, Director, Division of Good Manufacturing Practice Assessment, CDER, FDA, will present. Talton is a co-inventor of Nanotherapeutics' technologies and has several authored peer-reviewed publications and book chapters involved in drug delivery systems with a primary focus in drug analysis and controlled release formulations, pharmacokinetics, and pulmonary drug delivery.

“These expert speakers will serve as outstanding leads into this new conference that explores advances in biopharmaceutical manufacturing, facility design and integration to help companies develop and validate future projects and next-generation manufacturing systems,” said Nancy Berg, President/CEO of ISPE.

Attendee registration is open. Those interested can learn more at http://www.ISPE.org/2013BioTechConference.

About ISPE
ISPE, the International Society for Pharmaceutical Engineering, is the world’s largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Tampa, Florida, USA and offices in Brussels, Belgium, Singapore and Shanghai, China. Visit http://www.ISPE.org for more information.

###

Read the full story at http://www.prweb.com/releases/2013/7/prweb10966374.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dr. Rongxiang Xu, Patent Owner of Damaged Organ Regeneration, a Top Priority Addressed in the 2013 Presidential State of The Union, Files Lawsuit Against 2012 Nobel Laureate Dr. Yamanaka for Deception
2. Dr. Rongxiang Xu, Owner of Patented Technology to Regenerate Damaged Organs, Announces Lawsuit Against 2012 Nobel Laureate Dr. Shinya Yamanaka
3. Une plainte contre une organisation du Prix Nobel pour diffamation et concurrence deloyale est déposée pour la première fois
4. Erste Klage gegen Nobelpreis-Organisation wegen Verleumdung und unlauterem Wettbewerb eingereicht
5. First Suit Against Nobel Prize Organization Citing Defamation And Unfair Competition Practices Is Filed
6. Specialty Chemical Forum 2012 Kicks Off in Houston; AkzoNobels Frank Sherman Delivers Keynote Address
7. Telome Health Co-founder and Nobel Laureate Elizabeth Blackburn Awarded Innovator of the Year
8. Syngentas Mary-Dell Chilton named 2013 World Food Prize laureate
9. The Energy Scientific World Acclaims the Global Energy Prize 2012 Laureates
10. Laureate Biopharma Names James D. Utterback to Board of Directors
11. Laureate Biopharma Appoints Les Mintzmyer, Vice President, Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
(Date:6/23/2016)... -- On Wednesday, June 22, 2016, the NASDAQ ... Dow Jones Industrial Average edged 0.27% lower to finish at ... Stock-Callers.com has initiated coverage on the following equities: Infinity Pharmaceuticals ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ... Learn more about these stocks by accessing their free trade ...
(Date:6/23/2016)... ... 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), a ... webinar on Performing Quality Investigations: Getting to Root Cause. This ... charge. , Incomplete investigations are still a major concern to the Regulatory Authorities ...
(Date:6/23/2016)... June 22, 2016  Amgen (NASDAQ: AMGN ... QB3@953 life sciences incubator to accelerate the ... shared laboratory space at QB3@953 was created to help ... obstacle for many early stage organizations - access to ... sponsorship, Amgen launched two "Amgen Golden Ticket" awards, providing ...
Breaking Biology Technology:
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):